| Literature DB >> 17335084 |
Michelle L Steinhilb1, Dora Dias-Santagata, Erin E Mulkearns, Joshua M Shulman, Jacek Biernat, Eva-Maria Mandelkow, Mel B Feany.
Abstract
The microtubule-associated protein tau is hyperphosphorylated abnormally in AD and related neurodegenerative disorders. Many phospho epitopes created by proline directed kinases (SP/TP sites) show relative specificity for disease states. To test whether phosphorylation at the disease-associated SP/TP sites affects tau toxicity in vivo, we expressed a form of tau in Drosophila in which all SP/TP sites are mutated to alanine. We find that blocking phosphorylation at SP/TP motifs markedly reduces tau toxicity in vivo. Using phosphorylation-specific antibodies, we identify a positive correlation between increased phosphorylation at disease-associated sites and neurotoxicity. We use the phosphorylation-incompetent version of tau to show that kinase and phosphatase modifiers of tau neurotoxicity, including cdk5/p35, the JNK kinase hemipterous and PP2A act via SP/TP phosphorylation sites. We provide direct evidence in an animal model system to support the role of phosphorylation at SP/TP sites in playing a critical role in tau neurotoxicity. (c) 2007 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17335084 DOI: 10.1002/jnr.21232
Source DB: PubMed Journal: J Neurosci Res ISSN: 0360-4012 Impact factor: 4.164